Relationship between advanced glycation end-product accumulation and low skeletal muscle mass in Japanese men and women

2016 ◽  
Vol 17 (5) ◽  
pp. 785-790 ◽  
Author(s):  
Michitaka Kato ◽  
Akira Kubo ◽  
Yosuke Sugioka ◽  
Rie Mitsui ◽  
Nobuki Fukuhara ◽  
...  
2005 ◽  
Vol 37 (Supplement) ◽  
pp. S301
Author(s):  
Taishi Midorikawa ◽  
Takashi Abe ◽  
Kiyoshi Sanada ◽  
Charles F. Kearns ◽  
Tetsuo Fukunaga

2018 ◽  
Vol 74 (9) ◽  
pp. 1446-1453 ◽  
Author(s):  
Yasuharu Tabara ◽  
Tome Ikezoe ◽  
Mikihiro Yamanaka ◽  
Kazuya Setoh ◽  
Hiroaki Segawa ◽  
...  

Abstract Background The accumulation of advanced glycation end product (AGE) might exert deleterious effects on musculoskeletal properties. Our study aims to clarify this possible association in a large general population. Methods This study investigated a general population of 9,203 patients (mean age, 57.8 years). Skeletal muscle mass was measured by bioelectrical impedance analysis, whereas accumulation of AGEs was assessed by skin autofluorescence (SAF-AGE). The muscle strength of upper and lower limbs and usual gait speed were measured in a portion of older (≥60 years of age) participants (n = 1,934). The speed of sound (SOS) in the calcaneal bone was assessed via a quantitative ultrasound technique. Results In the total population, the frequency of low skeletal muscle mass linearly increased with the SAF-AGE quartiles (Q1: 14.2%, Q2: 16.1%, Q3: 21.1%, Q4: 24.8%; p < .001), and this association was independent of covariates including glycemic traits (Q4: odds ratio [OR] = 1.48, p < .001). The association between the highest SAF-AGE quartile and low skeletal muscle mass remained significant in the older subpopulation (OR = 1.85, p = .002). A similar but weak association was observed for low SOS (Q1: 8.9%, Q2: 8.3%, Q3: 10.4%, Q4: 12.2%; p < .001). Similar inverse associations were also observed with grip strength (OR = 1.98, p = .003), hip flexion strength (OR = 1.50, p = .012), and hip abduction strength (OR = 1.78, p = .001), but not with usual gait speed. Conclusion Accumulation of AGEs might be a deleterious factor for musculoskeletal properties.


2005 ◽  
Vol 37 (Supplement) ◽  
pp. S301
Author(s):  
Taishi Midorikawa ◽  
Takashi Abe ◽  
Kiyoshi Sanada ◽  
Charles F. Kearns ◽  
Tetsuo Fukunaga

2008 ◽  
Vol 33 (4) ◽  
pp. 769-774 ◽  
Author(s):  
Jennifer L. Kuk ◽  
Katherine Kilpatrick ◽  
Lance E. Davidson ◽  
Robert Hudson ◽  
Robert Ross

The relationship between skeletal muscle mass, visceral adipose tissue, insulin sensitivity, and glucose tolerance was examined in 214 overweight or obese, but otherwise healthy, men (n = 98) and women (n = 116) who participated in various exercise and (or) weight-loss intervention studies. Subjects had a 75 g oral glucose tolerance test and (or) insulin sensitivity measures by a 3 h hyperinsulinemic–euglycemic clamp technique. Whole-body skeletal muscle mass and visceral adipose tissue were measured using a multi-slice magnetic resonance imaging protocol. Total body skeletal muscle mass was not associated with any measure of glucose metabolism in men or women (p > 0.10). These observations remained independent of age and total adiposity. Conversely, visceral adipose tissue was a significant predictor of various measures of glucose metabolism in both men and women with or without control for age and (or) total body fat (p < 0.05). Although skeletal muscle is a primary site for glucose uptake and deposition, these findings suggest that unlike visceral adipose tissue, whole-body skeletal muscle mass per se is not associated with either glucose tolerance or insulin sensitivity in overweight and obese men and women.


2020 ◽  
Vol 4 (Supplement_2) ◽  
pp. 589-589
Author(s):  
Julie Jones ◽  
Sujatha Rajaram ◽  
Celine Heskey ◽  
Rawiwan Sirirat ◽  
Abigail Clarke ◽  
...  

Abstract Objectives We sought to assess the effect of daily consumption of macadamia nuts as 15% of calories on body weight, BMI, waist circumference, percent body fat and skeletal muscle mass in overweight/obese men and women with elevated cardiometabolic risk. Methods Utilizing a randomized crossover design, we randomized 38 subjects to consume macadamia nuts daily as 15% of calories for 8 weeks (intervention) and their usual diet for 8 weeks (control), with a 2-week washout. Three subjects dropped out early; n = 35 for analysis. Subjects were healthy men and postmenopausal women with a BMI of 25–39, a waist circumference of &gt;101.6 cm for men and &gt;88.9 cm for women, and one additional cardiovascular risk factor (fasting plasma glucose &gt;100 mg/dL, triglycerides ≥150 mg/dl, total cholesterol &gt;200 mg/dL, LDL-C &gt; 100 mg/dL, blood pressure ≥130/85 mmHg or taking anti-hypertensive medication). Macadamia nuts were provided in pre-weighed daily portions as 15% of calories calculated using the Mifflin-St. Jeor equation. Percent body fat and skeletal muscle mass (kg) were determined by bioelectrical impedance analysis. A mixed model analysis was performed with treatment, sequence, phase, and baseline values as fixed-effect terms and subjects as a random-effects term. Results Compared to control, consumption of macadamia nuts led to a mean weight change of –348 g (84.13 vs. 83.78 kg; P = 0.15) a mean BMI change of –0.15 kg/m2 (30.61 vs. 30.47 kg/m2; P = 0.12), and a mean waist circumference change of 0.17 cm (107.41 vs. 107.58 cm; P = 0.61). Percent body fat increased by an average of 0.26% after eating nuts (42.70 vs. 42.96%; P = 0.16). Skeletal muscle mass was slightly but significantly lower after eating nuts with a mean change of –0.237 kg (26.33 vs. 26.09 kg; P = 0.017). Conclusions Daily consumption of high-fat macadamia nuts for eight weeks in overweight and obese individuals did not change anthropometrics including body weight, BMI, waist circumference, and % body fat. Skeletal muscle mass was slightly lowered but likely not clinically relevant. Funding Sources Hort Innovation, Sydney, Australia.


1999 ◽  
Vol 107 (2) ◽  
pp. 123-136 ◽  
Author(s):  
Richard N. Baumgartner ◽  
Debra L. Waters ◽  
Dympna Gallagher ◽  
John E. Morley ◽  
Philip J. Garry

Sign in / Sign up

Export Citation Format

Share Document